Faga Daniel
- SEC CIK
- 0001673528
In the past year, 4 open-market sale filings worth $2.81M and no purchases.
Current role at each company
- TRAX First Tracks Biotherapeutics, Inc.President, CEOas of Aug 18, 2026
- ANAB Anaptysbio, IncPresident, CEOas of Aug 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.81M
- 4 filings
- Net
- −$2.81M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Faga Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ANAB Anaptysbio, Inc
President, CEO6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 (view filing) | Mar 27 | Same day | Faga DanielPresident, CEO | SSale | −17.7K | $61.61 | −$1.09M | −3.4%496.0K after | 10 lots |
| Jan 9, 2026 (view filing) | Jan 8 | 1 day | Faga DanielPresident, CEO | SSale | −14.3K | $44.71 | −$638.5K | −2.9%479.3K after | |
| Jan 8, 2026 (view filing) | Jan 7 | 1 day | Faga DanielPresident, CEO | SSale | −9.20K | $45.11 | −$415.1K | −1.9%466.8K after | |
| Jan 6, 2026 (view filing) | Jan 5 | 1 day | Faga DanielPresident, CEO | SSale | −15.3K | $43.26 | −$662.3K | −3.2%458.1K after | |
| Mar 26, 2024 (view filing) | Mar 22-25 | 4 days | Faga DanielCEO | SSale | −148.9K | $22.75 | −$3.39M | −16.6%749.1K after | 2 lots |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Faga DanielCEO | SSale | −6.87K | $21.81 | −$149.7K | −0.8%898.0K after |